RxDoctor Payments Data

Sarah Babineaux, APRN

Family · Covington, LANPI 1235584574

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $783, 3.3 times the $240 reported in 2022.

$1,868in general payments, 2019–2025

Across 19 payments — averaging $98.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$375
  • Lilly USA, LLC$186
  • Johnson & Johnson$146
  • Amgen$135
  • AstraZeneca$122
  • Neurelis, Inc.$121
  • plus $782 from 8 others

What the payments were for

  • Food & beverage$1,868100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,868 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana →

Medicare billing

Part B allowed, 2024
$2,688
Medicare patients
47
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl98$2,222
Fluticasone Propionate98$1,052
Doxycycline Hyclate38$326
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$259
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$247
Mupirocin25$203
Ibuprofen27$101
Tizanidine Hcl23$98
Cephalexin18$74
Methocarbamol13$44

Paid to pharmacies, not to this prescriber.

Other family in Covington

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →